Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
SENACYT
Panama CityPre-Seed–Growth$150K
2 people
NJF Capital
LondonSeed–Late Stage
1 person
WERU Investment Co. Ltd.
TokyoPre-Seed–Growth
1 person
MSA Capital
Grand CaymanPre-Seed–Late Stage$1.4M – $130M
3 people
East West Capital Limited
SydneyPre-Seed–Late Stage
1 person
Panda Capital
Pre-Seed–Late Stage
1 person
venture / science
San Francisco Bay AreaSeed–Late Stage
1 person
BDC Climate Tech Fund II
MontréalSeed–Growth
Zhongguancun Development Group
BeijingPre-Seed–Growth
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Late Stage
1 person
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
Oikos Ventures
MontevideoSeed–Growth
1 person
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
1 person
Teewinot Ventures
Pre-Seed–Late Stage
1 person
TriWise Capital
ShenzhenPre-Seed–Late Stage
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
Hefei High-tech VC
HefeiSeed–Series C
E15
Hong KongPre-Seed–Late Stage
GERBER-RAUTH
MilanPre-Seed–Late Stage
Anais Ventures
LancySeries A–Series C
3 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.



